Reported Standalone quarterly numbers for Suven Life Sciences are:
Net Sales at Rs 1.01 crore in June 2024 down 73.51% from Rs. 3.80 crore in June 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 7.67 crore in June 2024 down 167.05% from Rs. 2.87 crore in June 2023.
EBITDA stands negative at Rs. 6.15 crore in June 2024 down 430.17% from Rs. 1.16 crore in June 2023.
Suven Life Sci shares closed at 135.23 on August 05, 2024 (NSE) and has given 24.18% returns over the last 6 months and 116.37% over the last 12 months.
Story continues below Advertisement
| Suven Life Sciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 1.01 | 2.39 | 3.80 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1.01 | 2.39 | 3.80 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 4.69 | 3.46 | 4.54 | | Depreciation | 1.49 | 1.51 | 1.66 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | 4.18 | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 6.40 | 1.61 | 6.05 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -11.57 | -8.38 | -8.46 | | Other Income | 3.93 | 4.28 | 5.64 | | P/L Before Int., Excpt. Items & Tax | -7.64 | -4.10 | -2.82 | | Interest | 0.02 | 0.03 | 0.05 | | P/L Before Exceptional Items & Tax | -7.67 | -4.13 | -2.87 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -7.67 | -4.13 | -2.87 | | Tax | -- | -1.00 | -- | | P/L After Tax from Ordinary Activities | -7.67 | -3.12 | -2.87 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -7.67 | -3.12 | -2.87 | | Equity Share Capital | 21.81 | 21.81 | 21.81 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.35 | -0.14 | -0.13 | | Diluted EPS | -0.35 | -0.14 | -0.13 | | EPS After Extra Ordinary | | Basic EPS | -0.35 | -0.14 | -0.13 | | Diluted EPS | -0.35 | -0.14 | -0.13 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
